The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As for the R9C, the arginine 25 was mutated into a cysteine with cardiotoxic effects associated with SERCA super-inhibition and arrhythmia[23].”
From Effects of the Arg9Cys and Arg25Cys mutations on phospholamban's conformational equilibrium in membrane bilayers (2018) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Truncations of titin causing dilated cardiomyopathy
Herman, D. S., Lam, L., Taylor, M. R. G., Wang, L., Teekakirikul, P., Christodoulou, D., Conner, L., DePalma, S. R., McDonough, B., Sparks, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110186 · Cited by 1,485
Phospholamban: a crucial regulator of cardiac contractility
MacLennan, D. H., & Kranias, E. G. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1151 · Cited by 1,088
Self-citationAlterations of Sarcoplasmic Reticulum Proteins in Failing Human Dilated Cardiomyopathy
Meyer, M., Schillinger, W., Pieske, B., Holubarsch, C., Heilmann, C., Posival, H., Kuwajima, G., Mikoshiba, K., Just, H., & Hasenfuss, G. (1995) · Circulation · doi:10.1161/01.cir.92.4.778 · Cited by 535
Jaski, B. E., Jessup, M. L., Mancini, D. M., Cappola, T. P., Pauly, D. F., Greenberg, B., Borow, K., Dittrich, H., Zsebo, K. M., & Hajjar, R. J. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.01.013 · Cited by 457
del Monte, F., Williams, E., Lebeche, D., Schmidt, U., Rosenzweig, A., Gwathmey, J. K., Lewandowski, E. D., & Hajjar, R. J. (2001) · Circulation · doi:10.1161/hc3601.095574 · Cited by 382
Zsebo, K., Yaroshinsky, A., Rudy, J. J., Wagner, K., Greenberg, B., Jessup, M., & Hajjar, R. J. (2014) · Circulation Research · doi:10.1161/circresaha.113.302421 · Cited by 315
Research works printed but not linked: 39
- Hershberger, 2013, Dilated cardiomyopathy: the complexity of a diverse genetic architecture, Nat Rev Cardiol, 10, 531, 10.1038/nrcardio.2013.105 · DOI · Paper page
- Beuckelmann, 1992, Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure, Circulation, 85, 1046, 10.1161/01.CIR.85.3.1046 · DOI · Paper page
- Gwathmey, 1987, Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure, Circ Res, 61, 70, 10.1161/01.RES.61.1.70 · DOI · Paper page
- Hasenfuss, 1998, Alterations of calcium-regulatory proteins in heart failure, Cardiovasc Res, 37, 279, 10.1016/S0008-6363(97)00277-0 · DOI · Paper page
- Kranias, 2012, Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome, Circ Res, 110, 1646, 10.1161/CIRCRESAHA.111.259754 · DOI · Paper page
- Haghighi, 2001, Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure, J Biol Chem, 276, 24145, 10.1074/jbc.M102403200 · DOI · Paper page
- Haghighi, 2003, Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human, J Clin Invest, 111, 869, 10.1172/JCI17892 · DOI · Paper page
- Schmitt, 2003, Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban, Science, 299, 1410, 10.1126/science.1081578 · DOI · Paper page
- Haghighi, 2006, A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy, Proc Natl Acad Sci USA, 103, 1388, 10.1073/pnas.0510519103 · DOI · Paper page
- Posch, 2009, Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes, Heart Rhythm, 6, 480, 10.1016/j.hrthm.2009.01.016 · DOI
- van Rijsingen, 2014, Outcome in Phospholamban R14del Carriers: Results of a Large Multicentre Cohort Study, Circ Cardiovasc Genet, 7, 455, 10.1161/CIRCGENETICS.113.000374 · DOI · Paper page
- Cowan, 2010, Morphological analysis of 13 LMNA variants identified in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy, Circ Cardiovasc Genet, 3, 6, 10.1161/CIRCGENETICS.109.905422 · DOI
- Parks, 2008, Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy, Am Heart J, 156, 161, 10.1016/j.ahj.2008.01.026 · DOI · Paper page
- Norton, 2013, Exome sequencing and genome-wide linkage analysis in 17 families illustrate the complex contribution of TTN truncating variants to dilated cardiomyopathy, Circ Cardiovasc Genet, 6, 144, 10.1161/CIRCGENETICS.111.000062 · DOI
- Hu, 2010, Altered intracellular Ca2+ regulation in chronic rat heart failure, J Physiol Sci, 60, 85, 10.1007/s12576-009-0070-6 · DOI
- Luo, 1994, Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation, Circ Res, 75, 401, 10.1161/01.RES.75.3.401 · DOI · Paper page
- Arvanitis, 2007, Histidine-rich Ca-binding protein interacts with sarcoplasmic reticulum Ca-ATPase, Am J Physiol Heart Circ Physiol, 293, H1581, 10.1152/ajpheart.00278.2007 · DOI
- Knollmann, 2006, Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia, J Clin Invest, 116, 2510
- Kadambi, 1996, Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice, J Clin Invest, 97, 533, 10.1172/JCI118446 · DOI · Paper page
- Wehrens, 2005, Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure, Proc Natl Acad Sci USA, 102, 9607, 10.1073/pnas.0500353102 · DOI · Paper page
- Zima, 2010, Ca(2)+ spark-dependent and -independent sarcoplasmic reticulum Ca(2)+ leak in normal and failing rabbit ventricular myocytes, J Physiol, 588, 4743, 10.1113/jphysiol.2010.197913 · DOI · Paper page
- Shannon, 2003, Elevated sarcoplasmic reticulum Ca2+ leak in intact ventricular myocytes from rabbits in heart failure, Circ Res, 93, 592, 10.1161/01.RES.0000093399.11734.B3 · DOI · Paper page
- Shan, 2010, Role of chronic ryanodine receptor phosphorylation in heart failure and beta-adrenergic receptor blockade in mice, J Clin Invest, 120, 4375, 10.1172/JCI37649 · DOI · Paper page
- van Oort, 2010, Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure, Circulation, 122, 2669, 10.1161/CIRCULATIONAHA.110.982298 · DOI · Paper page
- Hershberger, 2011, Update 2011: clinical and genetic issues in familial dilated cardiomyopathy, J Am Coll Cardiol, 57, 1641, 10.1016/j.jacc.2011.01.015 · DOI · Paper page
- McNair, 2011, SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism, J Am Coll Cardiol, 57, 2160, 10.1016/j.jacc.2010.09.084 · DOI · Paper page
- van Spaendonck-Zwarts, 2011, Desmin-related myopathy, Clin Genet, 80, 354, 10.1111/j.1399-0004.2010.01512.x · DOI · Paper page
- Zvaritch, 2000, The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility, J Biol Chem, 275, 14985, 10.1074/jbc.275.20.14985 · DOI
- Zhai, 2000, Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo, J Biol Chem, 275, 10538, 10.1074/jbc.275.14.10538 · DOI
- Muller, 2003, Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload, Cardiovasc Res, 59, 380, 10.1016/S0008-6363(03)00429-2 · DOI
- del Monte, 2002, Targeting phospholamban by gene transfer in human heart failure, Circulation, 105, 904, 10.1161/hc0802.105564 · DOI · Paper page
- Hoshijima, 2002, Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery, Nat Med, 8, 864, 10.1038/nm739 · DOI · Paper page
- Zhang, 2004, Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure, Cardiovasc Res, 63, 476, 10.1016/j.cardiores.2004.04.026 · DOI · Paper page
- Wehrens, 2004, Ca2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor, Circ Res, 94, e61, 10.1161/01.RES.0000125626.33738.E2 · DOI · Paper page
- Eshete, 2001, Spike frequency decoding and autonomous activation of Ca2+-calmodulin-dependent protein kinase II in dorsal root ganglion neurons, J Neurosci, 21, 6694, 10.1523/JNEUROSCI.21-17-06694.2001 · DOI
- Anderson, 1998, KN-93, an inhibitor of multifunctional Ca2+/calmodulin-dependent protein kinase, decreases early afterdepolarizations in rabbit heart, J Pharmacol Exp Ther, 287, 996, 10.1016/S0022-3565(24)37893-0 · DOI · Paper page
- Curran, 2014, Nitric oxide-dependent activation of CaMKII increases diastolic sarcoplasmic reticulum calcium release in cardiac myocytes in response to adrenergic stimulation, PLoS One, 9, e87495, 10.1371/journal.pone.0087495 · DOI
- Erickson, 2013, Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation, Nature, 502, 372, 10.1038/nature12537 · DOI · Paper page
- Kimura, 1996, Phospholamban regulates the Ca2+-ATPase through intramembrane interactions, J Biol Chem, 271, 21726, 10.1074/jbc.271.36.21726 · DOI · Paper page
Cited by
Dilated Cardiomyopathy: Genetic Determinants and Mechanisms
McNally, E. M., & Mestroni, L. (2017) · Circulation Research · doi:10.1161/circresaha.116.309396 · Cited by 786
“Early onset DCM with lethal ventricular arrhythmias was described.(101,102) Similarly, individuals from the Netherlands with the R14del founder mutation have a severe phenotype.”
Schultheiss, H.-P., Fairweather, D., Caforio, A. L. P., Escher, F., Hershberger, R. E., Lipshultz, S. E., Liu, P. P., Matsumori, A., Mazzanti, A., McMurray, J., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0084-1 · Cited by 720
Self-citationCalcium Signaling and Cardiac Arrhythmias
Landstrom, A. P., Dobrev, D., & Wehrens, X. H. T. (2017) · Circulation Research · doi:10.1161/circresaha.117.310083 · Cited by 568
Advances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies
Yotti, R., Seidman, C. E., & Seidman, J. G. (2019) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083118-015306 · Cited by 168
Nelson, S. E. D., Ha, K. N., Gopinath, T., Exline, M. H., Mascioni, A., Thomas, D. D., & Veglia, G. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.02.030 · Cited by 16
Metadata
- Authors
- Liu, G.-S., Morales, A., Vafiadaki, E., Lam, C. K., Cai, W.-F., Haghighi, K., Adly, G., Hershberger, R. E., & Kranias, E. G.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-07
- Volume
- 107
- Issue
- 1
- Pages
- 164-174
- ISSN
- 1755-3245
- 0008-6363
- Cited by
- 81
- References
- 6
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.